Mesothelioma Hub is a trusted resource dedicated to supporting those affected by mesothelioma. Our team of medical and legal experts bring insightful, reliable, and recent information on mesothelioma healthcare, from survivor stories and medical breakthroughs to guidance on treatment options and connecting with specialists.
Researchers are currently studying a new promising drug for people with mesothelioma in hopes of moving closer to eliminating tumors. This mesothelioma oral medication is being included in a phase 1, multi-center, open-label study to evaluate the safety, tolerability, and PK of VT3989 in patients with refractory locally advanced [...]
In a recent study conducted by a team of scientists in Italy, the antitumoral effects of Bortezomib Velcade were explored, igniting excitement within the medical community and among patients and their families. The findings, published in April 2023, promised results that have the potential to reshape the landscape of [...]
New research shows that genetic inheritance of the BAP1 protein mutation could lead to an eventual diagnosis of mesothelioma, the deadly cancer caused by prolonged asbestos exposure. This research started a spiral of new research looking into the two types of BAP1 genes, an inherited germline BAP1 mutation from [...]
The International Mesothelioma Program is a center for mesothelioma research and treatment at the Brigham and Women’s Hospital in Boston, Massachusetts. Since 2002, the team of more than 80 caregivers, scientists, and support staff have worked to develop new treatment strategies and improve the quality of life for mesothelioma [...]
On July 22 and 23 of 2022, the Mesothelioma Applied Research Foundation (MARF) will hold its annual International Symposium on Malignant Mesothelioma in Chicago, Illinois. MARF is the only nonprofit charitable organization dedicated to ending mesothelioma and its detrimental effects. Since 2004, MARF has gathered prominent mesothelioma experts alongside [...]
Mesothelioma, an uncommon but deadly type of cancer, was diagnosed in over 30,800 people worldwide in 2020. Although there are many known forms of treatment, such as chemotherapy, medical professionals still perform research to determine alternative treatment options. Clinical trials are experimental studies to determine the efficacy and safety [...]
The second phase of a clinical trial is actively recruiting patients diagnosed with malignant pleural mesothelioma. The study is using a multimodal treatment approach involving surgery, radiation therapy, and chemotherapy, and has spaces available for 81 eligible participants. Researchers at Memorial Sloan-Kettering Cancer Center and other locations across the [...]
